Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Tong Ren Tang Technologies Co. Ltd.

Market Cap 3.55B 4.11B 524M 458M 424M 396M 743M 49.56B 748M 5.04B 1.96B 24.36B 1.97B 1.93B 84.64B P/E 2026 *
7.81x
P/E 2027 * 6.93x
Enterprise Value 3.55B 4.11B 524M 458M 424M 396M 743M 49.56B 748M 5.04B 1.96B 24.36B 1.97B 1.93B 84.64B EV / Sales 2026 *
0.51x
EV / Sales 2027 * 0.47x
Free-Float
45.7%
Yield 2026 *
5.77%
Yield 2027 * 6.49%
05-26 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
04-27 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
03-30 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
03-27 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
03-27 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-27 Tong Ren Tang Technologies Co. Ltd. announces Annual dividend, payable on August 11, 2026 CI
02-06 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
01-13 Tong Ren Tang Technologies Co. Ltd. Announces Resignation of Li Siu Bun from the Positions as an Independent Non-Executive Director, Chairman of the Audit Committee of the Board and A Member of Each of the Remuneration Committee of the Board and the Strategy and Planning Committee CI
12-30 Tong Ren Tang Technologies Co. Ltd. Announces Board Changes CI
11-28 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective November 28, 2025 CI
11-28 Tong Ren Tang Technologies Co., Ltd. Enters into Supplemental Trademark Framework Agreement with Tong Ren Tang Holdings CI
11-28 Tong Ren Tang Technologies Co. Ltd. Announces Resignation of Chen Fei as Non-Executive Director CI
28/10/25 Tong Ren Tang Technologies says 9m unaudited net profits attributable RMB416.26 million RE
1 day+2.49%
1 week-2.95%
Current month-6.53%
1 month-8.36%
3 months-16.50%
6 months-25.23%
Current year-25.40%
1 week 3.2
Extreme 3.2
3.38
1 month 3.2
Extreme 3.2
3.67
Current year 3.2
Extreme 3.2
4.56
1 year 3.2
Extreme 3.2
5.52
3 years 3.2
Extreme 3.2
7.8
5 years 3.2
Extreme 3.2
9.28
10 years 3.2
Extreme 3.2
16
Manager TitleAgeSince
Chief Executive Officer 58 04/06/2025
Compliance Officer 47 28/11/2025
Comptroller/Controller/Auditor 48 04/06/2025
Director TitleAgeSince
Director/Board Member 67 10/02/2011
Director/Board Member 69 12/06/2018
Director/Board Member 82 12/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
+2.49%-2.95%-31.03%-53.33% 538M
+0.47%-2.97%-11.58%-7.05% 12.77B
+0.21%-5.16%-34.57%-56.61% 4.76B
-0.83%-7.65%-13.37%-4.03% 4.34B
-0.13%-2.53%+15.71%-15.38% 3.8B
+0.20%-5.52%+8.20%-41.30% 3.71B
-0.66%-4.53%-5.99%-8.95% 3.53B
-2.84%-5.78%-11.68%-3.05% 3.11B
-1.11%-2.77%-5.15%-25.12% 2.38B
-0.94%-5.00%-12.63%+31.12% 1.67B
Average -0.31%-4.98%-10.21%-18.37% 4.06B
Weighted average by Cap. -0.26%-4.41%-9.55%-16.40%

Financials

2026 *2027 *
Net sales 6.98B 8.08B 1.03B 901M 833M 778M 1.46B 97.41B 1.47B 9.9B 3.85B 47.89B 3.87B 3.79B 166B 7.56B 8.75B 1.12B 976M 902M 842M 1.58B 106B 1.59B 10.72B 4.17B 51.88B 4.19B 4.1B 180B
Net income 454M 526M 67.1M 58.63M 54.23M 50.62M 95.03M 6.34B 95.72M 644M 251M 3.12B 252M 246M 10.83B 514M 594M 75.81M 66.24M 61.27M 57.19M 107M 7.16B 108M 728M 283M 3.52B 285M 278M 12.24B
Net Debt - -
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
3,951
Date Price Change Volume
23/06/26 3.290 $ +2.49% 1,571,000
22/06/26 3.210 $ -2.43% 1,502,000
18/06/26 3.290 $ -2.08% 1,699,100
17/06/26 3.360 $ -0.88% 616,000
16/06/26 3.390 $ -4.78% 665,000
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.773CNY
Average target price
4.601CNY
Spread / Average Target
+65.91%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1666 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!